SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001657312-21-000020
Filing Date
2021-08-05
Accepted
2021-08-05 16:21:59
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrna-20210805.htm   iXBRL 8-K 48304
2 EX-99.1 exhibit991q221.htm EX-99.1 60552
6 image_0.jpg GRAPHIC 172284
  Complete submission text file 0001657312-21-000020.txt   502243

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20210805.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20210805_lab.xml EX-101.LAB 25632
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20210805_pre.xml EX-101.PRE 13521
7 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20210805_htm.xml XML 11751
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 211148563
SIC: 2834 Pharmaceutical Preparations